Similar articles

• [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].

  Arai H, Iizuka R. Arai H, et al. Nihon Rinsho. 1988 Jul;46(7):1491-5. Nihon Rinsho. 1988. PMID: 3221455 Japanese. No abstract available.
• Neurotransmitters in dementia.

  Nakamura S, Koshimura K, Kato T, Yamao S, Iijima S, Nagata H, Miyata S, Fujiyoshi K, Okamoto K, Suga H, et al. Nakamura S, et al. Clin Ther. 1984;7 Spec No:18-34. Clin Ther. 1984. PMID: 6152197
• Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.

  Whitehouse PJ. Whitehouse PJ. Adv Neurol. 1987;45:393-7. Adv Neurol. 1987. PMID: 2881448 No abstract available.
• An update on the neurochemistry of Alzheimer disease.

  Davies P. Davies P. Adv Neurol. 1983;38:75-86. Adv Neurol. 1983. PMID: 6137134 Review. No abstract available.
• The ageing brain and dementia--a review.

  Davison AN. Davison AN. Br J Clin Pract Suppl. 1985 Jun;39:3-6. Br J Clin Pract Suppl. 1985. PMID: 2864054 Review. No abstract available.